CSF2 and neoplasm: T-VEC is a genetically modified oncolytic virus that expresses granulocyte-macrophage colony-stimulating factor (GM-CSF).48,49 It selectively infects and replicates in tumour cells, which not only leads to cell lysis but also to the release of GM-CSF.